-

Kit Check Launches Kit Check Professional Services to Offer Hospitals Hands-On Support for Drug Diversion Programs

Portfolio of services employs dedicated specialist to operationalize drug diversion activities using Bluesight® for Controlled Substances

WASHINGTON--(BUSINESS WIRE)--Kit Check, the leading automation vendor in Medication Intelligence™ solutions that brings cost savings, efficiency, and patient safety to hospitals, today announced the launch of Kit Check Professional Services (KCPS) to help support hospitals in need of a hands-on approach to daily activities involved with their drug diversion program. KCPS is a customizable suite of service offerings that employs a dedicated specialist, overseen by Kit Check’s expert clinical team, to help hospitals understand and optimize their drug diversion programs that utilize the company’s Bluesight® for Controlled Substances (BCS) platform.

Some of the activities offered as part of KCPS include routine surveillance monitoring and interpretation to identify suspicious behavior, investigation analyses and support to enable a quicker turnaround time and reporting to analyze and measure performance and compliance metrics. These offerings help hospitals busy trying to run various programs ensure their drug diversion management is thoroughly overseen and enables them to identify any potential anomalies.

“At Kit Check, we understand that hospitals are trying to manage a wide variety of tasks, including drug diversion prevention,” said Jennifer Symon, R.Ph., MBA, FACHE, director of clinical solutions at Kit Check. “Kit Check Professional Services can help augment a hospital’s program and enable staff to devote time to other pressing tasks. The addition of a dedicated solutions consultant and account management team ensures that organizations can capitalize on the data and insight Bluesight for Controlled Substances is able to provide – they can feel confident that they have guardrails and a safety net for program compliance and accountability, and can identify issues on the horizon that they may not have been able to otherwise.”

Kit Check’s offerings for KCPS are completely customizable to meet the needs of an individual hospital or health system. They can be deployed for short-term projects, teaching customers to effectively manage their own drug diversion program through the use of BCS or full-time engagements for those looking for ongoing support.

To learn more about Kit Check Professional Services, visit: https://kitcheck.com/professional-services/

About Kit Check
Kit Check® is the leading provider of automated medication tracking and diversion detection solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management. Our groundbreaking Medication Intelligence™ solutions provide item level visibility, workflow simplicity and actionable analytics, empowering stakeholders to deliver the right medicine to the right patient at the right time, every time. To date, our more than 700 U.S. and Canadian hospital partners have adopted Kit Check solutions to solve the most challenging of healthcare problems. Kit Check Solutions help providers save time managing inventory, prevent diversion at their facilities, save money on medication spend, and ensure patient safety. More information about Kit Check and our software solutions can be found at kitcheck.com.

Contacts

Jill Gross
Matter Health for Kit Check
kitcheck@matternow.com

Kit Check


Release Summary
Kit Check launches Kit Check Professional Services to offer hospitals hands-on support for drug diversion programs.
Release Versions

Contacts

Jill Gross
Matter Health for Kit Check
kitcheck@matternow.com

More News From Kit Check

New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management

ALEXANDRIA, Va.--(BUSINESS WIRE)--BluesightⓇ, The Medication Intelligence™ Company, today published the results of a recent survey measuring U.S. consumers’ trust in the U.S. healthcare system and pharmaceutical industry, which revealed that trust in both is below average. The study also explored how prior knowledge about drug diversion – among other factors – may impact patient perception and decisions about where to seek care. “Through our suite of software solutions, Bluesight aims to provid...

Medication Intelligence Leader Kit CheckⓇ Rebrands as BluesightⓇ

LAS VEGAS--(BUSINESS WIRE)--Kit Check today announced that it has rebranded as BluesightⓇ, The Medication Intelligence™ Company, to reflect its comprehensive suite of software solutions, maintaining its commitment to helping hospitals better serve their patients and pursuing a future where the medication supply chain is more efficient and connected. Founded in 2011, Bluesight provides unit-level visibility of pharmaceutical products from manufacturing plant to patient, addressing challenges suc...

Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes

ALEXANDRIA, Va.--(BUSINESS WIRE)--Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its proprietary Radio Frequency Identification (RFID) technology will be incorporated in the new KinetiX™ Propofol syringes being developed by Genixus™, a pharmaceutical company and FDA-registered repackager and 503B outsourcing provider focused on transforming acute and critical care medicines. Propofol is one of the most commonly used products in hospitals and health sy...
Back to Newsroom